• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Influenza Other Respir Viruses . High seroprevalence of severe acute respiratory syndrome coronavirus 2 among healthcare workers in Yaoundé, Camero

tetano

Editor, Senior Moderator
Influenza Other Respir Viruses


. 2024 Feb;18(2):e13239.
doi: 10.1111/irv.13239. High seroprevalence of severe acute respiratory syndrome coronavirus 2 among healthcare workers in Yaoundé, Cameroon after the first wave of Covid-19 pandemic and associated factors

Mathurin Cyrille Tejiokem[SUP] 1 [/SUP], Hermine Abessolo Abessolo[SUP] 2 [/SUP], Joseph Mendimi Nkodo[SUP] 3 [/SUP], Mireille Ouethy[SUP] 3 [/SUP], Georges Bouting Mayaka[SUP] 4 [/SUP], Yannick Touha[SUP] 4 [/SUP], Ulrich Armel Dikoume[SUP] 5 [/SUP], Jules Brice Tchatchueng-Mbougua[SUP] 1 [/SUP], Diane Choualeu Noumbissi[SUP] 1 [/SUP], William Tsobeng Ndjeukam[SUP] 1 [/SUP], Hervé Odilon Otabela Mbarga[SUP] 1 [/SUP], Paul Alain Tagnouokam Ngoupo[SUP] 6 [/SUP], Charlotte Moussi[SUP] 7 [/SUP], Bonaventure Hollong Garoua[SUP] 2 [/SUP], Richard Njouom[SUP] 6 [/SUP], Vincent Richard[SUP] 8 [/SUP]



Affiliations
Abstract

Background: Healthcare workers (HWs) are at a high risk of exposure to emerging health threats. Following the first wave of the coronavirus disease 2019 pandemic in Cameroon, we explored the presence and persistence of naturally acquired antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the factors associated with seropositivity in HWs.
Methods: Staff at two referral hospitals in Yaoundé or two Health District Hospitals in Obala and Mbalmayo were included in a 6-month prospective cohort analysis or cross-sectional survey, respectively. Seroprevalence and associated factors were determined, and Kaplan-Meier curves and Cox proportional hazards models were used to assess antibody persistence or positive seroconversion over time.
Results: From August 2020 to March 2021, 426 HWs (median age: 31 years, interquartile range: 27-37 years; 66.4% female) were enrolled. The overall seroprevalence of anti-SARS-CoV-2 antibodies was 54.0% (95% confidence interval [CI]: 49.1-58.8) and was significantly different between study sites (p = 0.04). Of the 216 HWs included in the 6-month cohort, 109 (50.5%) HWs were seropositive at inclusion; the probability of persistent antibodies or of becoming seropositive was 93.8% (95% CI: 84.2-100) and 78.9% (95% CI: 61.7-88.4), respectively. Seroconversion was associated with study site and occupation but not with infection prevention and control (IPC) practices.
Conclusions: We observed high seroprevalence of SARS-CoV-2 antibody and seroconversion among HWs associated with occupational risk. This suggests low compliance to the COVID-19 control measures. Continued training and implementation of IPC measures and accelerated preparedness are needed to better tackle future threats.

Keywords: Cameroon; SARS-CoV-2 infection antibody testing; antibody persistence; health personnel; seroepidemiologic studies.

 
Back
Top Bottom